MARIA PILAR GONZALEZ CABO-rekin lankidetzan egindako argitalpenak (2)

2020

  1. Thioredoxin and glutaredoxin systems as potential targets for the development of new treatments in Friedreich’s ataxia

    Antioxidants, Vol. 9, Núm. 12, pp. 1-25

2017

  1. Circulating miR-323-3p is a biomarker for cardiomyopathy and an indicator of phenotypic variability in Friedreich's ataxia patients

    Scientific Reports, Vol. 7, Núm. 1